FdaApplication
NDA 210282
Identifiers
- fda_app_no: NDA210282
Properties
| Property | Value |
|---|---|
| applicant_name | HOSPIRA INC |
| application_type | NDA |
| approval_date | 2021-06-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPTOMYCIN | DAPTOMYCIN | 500MG/VIAL | POWDER;INTRAVENOUS |
| DAPTOMYCIN | DAPTOMYCIN | 350MG/VIAL | POWDER;INTRAVENOUS |
2 products